TROVATO, EMANUELE
 Distribuzione geografica
Continente #
NA - Nord America 1.636
EU - Europa 1.468
AS - Asia 1.004
SA - Sud America 248
Continente sconosciuto - Info sul continente non disponibili 97
AF - Africa 59
OC - Oceania 6
Totale 4.518
Nazione #
US - Stati Uniti d'America 1.592
RU - Federazione Russa 479
IT - Italia 334
SG - Singapore 292
CN - Cina 267
IE - Irlanda 210
BR - Brasile 200
VN - Vietnam 139
GB - Regno Unito 125
HK - Hong Kong 79
FR - Francia 61
SE - Svezia 56
KR - Corea 55
DE - Germania 54
BD - Bangladesh 53
FI - Finlandia 38
UA - Ucraina 31
ZA - Sudafrica 31
IN - India 29
CA - Canada 23
AR - Argentina 17
CZ - Repubblica Ceca 14
IQ - Iraq 14
NL - Olanda 14
TR - Turchia 13
EC - Ecuador 9
JP - Giappone 9
AT - Austria 8
PL - Polonia 8
BE - Belgio 7
ID - Indonesia 7
MX - Messico 7
PY - Paraguay 7
AU - Australia 6
CO - Colombia 6
ES - Italia 6
CI - Costa d'Avorio 5
DZ - Algeria 5
KE - Kenya 5
LT - Lituania 5
NG - Nigeria 5
AZ - Azerbaigian 4
MA - Marocco 4
MY - Malesia 4
NP - Nepal 4
PK - Pakistan 4
UZ - Uzbekistan 4
AL - Albania 3
CL - Cile 3
IL - Israele 3
JM - Giamaica 3
NI - Nicaragua 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
BH - Bahrain 2
BS - Bahamas 2
CH - Svizzera 2
DO - Repubblica Dominicana 2
EE - Estonia 2
ET - Etiopia 2
IR - Iran 2
JO - Giordania 2
LB - Libano 2
PE - Perù 2
PT - Portogallo 2
SA - Arabia Saudita 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
CR - Costa Rica 1
CY - Cipro 1
GD - Grenada 1
GI - Gibilterra 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MD - Moldavia 1
OM - Oman 1
PA - Panama 1
PH - Filippine 1
PS - Palestinian Territory 1
QA - Qatar 1
RO - Romania 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TJ - Tagikistan 1
TN - Tunisia 1
UY - Uruguay 1
Totale 4.422
Città #
Dallas 258
Dublin 208
Singapore 179
Moscow 133
San Jose 130
Ashburn 128
Santa Clara 127
Milan 112
Fairfield 80
Hefei 77
Southend 75
Beijing 74
Hong Kong 65
Chandler 63
Ho Chi Minh City 60
Council Bluffs 57
Seoul 53
Los Angeles 49
New York 41
Hanoi 39
Rome 38
Siena 38
Seattle 37
Woodbridge 36
Wilmington 32
Jacksonville 30
Ann Arbor 28
Johannesburg 27
Lauterbourg 26
Munich 26
Helsinki 23
Cambridge 22
Houston 20
São Paulo 20
Princeton 19
Shanghai 13
The Dalles 13
Bengaluru 12
Brno 12
Buffalo 12
Chicago 12
Columbus 12
Florence 10
Frankfurt am Main 10
Baghdad 9
London 9
Orem 9
Amsterdam 8
Denver 8
Messina 8
San Diego 8
Brussels 7
Curitiba 7
Miami 7
North Charleston 7
Redondo Beach 7
San Francisco 7
Tokyo 7
Turku 7
Boardman 6
Dearborn 6
Izmir 6
Manchester 6
Phoenix 6
Poplar 6
San Mateo 6
Warsaw 6
Abidjan 5
Abuja 5
Brooklyn 5
Guayaquil 5
Haiphong 5
Lappeenranta 5
Mumbai 5
Nanjing 5
Newark 5
Nuremberg 5
Portsmouth 5
Rio de Janeiro 5
Scandicci 5
Stockholm 5
Tianjin 5
Toronto 5
Atlanta 4
Brasília 4
Da Nang 4
Dong Ket 4
Fortaleza 4
Hyderabad 4
Mexico City 4
Nairobi 4
Paris 4
Philadelphia 4
Salvador 4
Tashkent 4
Vienna 4
Ananindeua 3
Asunción 3
Baku 3
Barnet 3
Totale 2.843
Nome #
Acquired a haemophilia: a case report 252
A case of inflammatory myofibroblastic tumour of the right labium majus 225
Evaluation of 11-β hydroxysteroid dehydrogenase type 1 in cutaneous fibroblasts cultures of psoriatic lesional skin before and after narrow band-UVB phototherapy 213
Neurothekeomas: Dermoscopic Features of 3 Cases 198
Pso-Reg: a web registry for psoriasis in real life 186
IGF1 synthesis after CO2 fractional laser resurfacing (FLR): New insights in the treatment of scalp actinic keratoses 177
Long-term drug survival of risankizumab in psoriasis: insights from a real-life multicenter study on hard-to-treat areas 176
Psoriasis successfully treated with guselkumab in a patient with systemic lupus erythematosus and acquired hemophilia A 163
Therapeutic Potential of Targeting the JAK/STAT Pathway in Psoriasis: Focus on TYK2 Inhibition 160
Sinecatechins 10% ointment for genital warts: Case report of a beneficial reaction in an HIV-positive woman 155
Anti-IL23for nail psoriasis in real life: Results of efficacy and safety during a 52-week period 152
An unusual triple association: superficial granulomatous pyoderma, subcorneal pustular dermatosis, IgA multiple myeloma 147
Secondary cutaneous and otosyphilis presenting with uncommon skin findings and triggering polycythemia vera 145
Clinical response to brodalumab in a patient affected by refractory SAPHO syndrome 143
Real-life effectiveness of Risankizumab according to body mass index: Results of an Italian multicentre retrospective study 131
Skin biopsy leading to diagnosis of diffuse intravascular B-cell lymphoma presenting as a fever of unknown origin 131
Association between apical periodontitis and psoriasis vulgaris: A cross‐sectional study 129
null 127
Signaling Pathways and Therapeutic Strategies in Advanced Basal Cell Carcinoma 125
Psoriasis and fibromyalgia: a systematic review 124
null 124
Teledermatology in 2020: Past, present and future perspectives 124
New-onset psoriasis after Comirnaty (BNT162b2, BioNTech/Pfizer) vaccine successfully treated with ixekizumab 121
Place in therapy of anti-IL-17 and 23 in psoriasis according to the severity of comorbidities: a focus on cardiovascular disease and metabolic syndrome 119
Treatment of periodontitis ameliorates the severity and extent of psoriasis—A randomized clinical trial 114
Real-World Efficacy of IL-23 Inhibitors in Psoriasis Affecting High-Impact Areas: Indirect Comparison of Tildrakizumab 200 mg, Risankizumab, and Guselkumab—IL PSO (Italian Landscape Psoriasis) 113
Six cases of tinea bullosa in Siena, Italy 99
The Immunogenetics of Psoriasis 95
Tuscany consensus for the treatment of moderate-severe psoriasis: update and focus on practical guidelines for place in therapy of anti-IL-17 and anti-IL-23 biologics 94
null 94
Effectiveness of Tildrakizumab 200 mg in Moderate-to-Severe Plaque Psoriasis: A Multicenter Real-World Study Analyzing Patient Outcomes by Weight, PASI, BMI, and Previous Therapies 78
Ixekizumab as treatment of erythrodermic psoriasis 67
Systemic Immune–Inflammation Index (SII) as a Predictive Biomarker of Therapeutic Response in Psoriasis: A Retrospective Comparative Analysis of Anti-TNF, Anti-IL-17, and Anti-IL-23 Agents 17
Totale 4.518
Categoria #
all - tutte 15.720
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.720


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022102 0 0 7 4 5 6 3 2 7 21 13 34
2022/2023259 13 20 39 21 25 50 6 23 16 2 31 13
2023/2024349 12 8 24 34 15 77 109 15 1 5 8 41
2024/2025746 11 40 100 47 94 34 15 43 52 34 67 209
2025/20262.328 156 308 245 329 422 78 205 56 64 130 126 209
2026/2027252 118 71 63 0 0 0 0 0 0 0 0 0
Totale 4.518